Differential gene expression in the peripheral zone compared to the transition zone of the human prostate gland

Prostate Cancer and Prostatic Diseases

Volumn 11, Issue 2, 2008, Pages 173-180

  Noel, E E ^a   Ragavan, N ^b,c   Walsh, M J ^b   James, S Y ^a   Matanhelia, S S ^c   Nicholson, C M ^c   Lu, Y J ^a   Martin, F L ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b LANCASTER UNIVERSITY   (United Kingdom)

^c LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BONE MORPHOGENETIC PROTEIN 5; CALVASCULIN; CLOSE HOMOLOGUE OF L1 PROTEIN; EPIDERMAL GROWTH FACTOR; GENE PRODUCT; GREMLIN 1; NEURAL EPIDERMAL GROWTH FACTOR LIKE LIKE PROTEIN 2; OLIGONUCLEOTIDE; SECRETED FRIZZLED RELATED PROTEIN 4; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 185;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CELL ADHESION; CELL MATURATION; CELL MOTILITY; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; HUMAN; HUMAN GENOME; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; NERVOUS SYSTEM DEVELOPMENT; NIDATION; NUCLEOTIDE SEQUENCE; PERIPHERAL ZONE; PRIORITY JOURNAL; PROSTATE; PROSTATE ADENOCARCINOMA; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSITION ZONE;

ADENOCARCINOMA; AGED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ORGAN SPECIFICITY; PROSTATE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 43549122153     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500997     Document Type: Article

References (28)

1. McNeal JE. The prostate gland: Morphology and pathobiology. Monograph Urol 1988; 9: 36-63.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global Cancer Statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
3. Grover PL, Martin FL. The initiation of breast and prostate cancer. Carcinogenesis 2002; 23: 1095-1102.
4. Grönberg H. Prostate cancer epidemiology. Lancet 2003; 361 859-864.
5. Kirschenbaum A, Liu XH, Yao S, Narla G, Friedman SL, Martignetti JA et al. Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones. Carcinogenesis 2006; 27: 216-224; doi:10.1093/carcin/bgi219.
6. Ragavan N, Hewitt R, Cooper LJ, Ashton KM, Hindley AC, Nicholson CM et al. CYP1B1 expression in prostate is higher in the peripheral than in the transition zone. Cancer Lett 2004; 215: 69-78.
7. Lexander H, Franzén B, Hirschberg D, Becker S, Hellström M, Bergman T et al. Differential protein expression in anatomical zones of the prostate. Proteomics 2005; 5: 2570-2576.
8. Laczkó I, Hudson DL, Freeman A, Feneley MR, Masters JR. Comparison of the zones of the human prostate with the seminal vesicle: Morphology, immunohistochemistry, and cell kinetics. Prostate 2005; 62: 260-266.
9. German MJ, Hammiche A, Ragavan N, Tobin MJ, Fullwood NJ, Matanhelia SS et al. Infrared spectroscopy with multivariate analysis potentially facilitates the segregation of different types of prostate cell. Biophys J 2006; 90: 3783-3795.
10. van der Heul-Nieuwenhuijsen L, Hendriksen PJM, van der Kwast TH, Jenster G. Gene expression profiling on the human prostate zones. BJU Int 2006; 98: 886-897.
11. Williams JA, Martin FL, Muir GH, Grover PL, Phillips DH. Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue. Carcinogenesis 2000; 21: 1683-1689.
12. Martin FL, Cole KJ, Muir GH, Kooiman GG, Williams JA, Sherwood RA et al. Primary cultures of prostate cells and their ability to activate carcinogens. Prostate Cancer Prostatic Dis 2002; 5: 96-104.
13. Daly-Burns B, Alam TN, Mackay A, Clark J, Shepherd CJ, Rizzo S et al A conditionally immortalized cell line model for the study of human prostatic epithelial cell differentiation. Differentiation 2007; 75: 35-48.
14. Michos O, Panman L, Vintersten K, Beier K, Zeller R, Zuniga A. Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 2004; 131: 3401-3410.
15. He B, Lee AY, Dadfarmay S, You L, Xu Z, Reguart N et al. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in β-catenin-deficient human mesothelioma cells. Cancer Res 2005; 65: 743-748.
16. Buhusi M, Midkiff BR, Gates AM, Richter M, Schachner M, Maness PF. Close homolog of L1 is an enhancer of integrin-mediated cell migration. J Biol Chem 2003; 278: 25024-25031.
17. Vanaja DK, Cheville JC, Iturria SJ, Young CYF. Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. Cancer Res 2003; 63: 3877-3882.
18. Zhang J-S, Gong A, Young CYF. ZNF185, an actin-cytoskeleton-associated growth inhibitory LIM protein in prostate cancer. Oncogene 2007; 26: 111-122.
19. Aihara K, Kuroda S, Kanayama N, Matsuyama S, Tanizawa K, Horie M. A neuron-specific EGF family protein, NELL2, promotes survival or neurons through mitogen-activated protein kinases. Mol Brain Res 2003; 116: 86-93.
20. Nelson BR, Matsuhashi S, Lefcort F. Restricted neural epidermal growth factor-like like 2 (NELL2) expression during muscle and neuronal differentiation. Mech Dev 2002; 119S: S11-S19.
21. DiLeone RJ, Marcus GA, Johnson MD, Kingsley DM. Efficient studies of long-distance Bmp5 gene regulation using bacterial artificial chromosomes. Proc Natl Acad Sci USA 2000; 97: 1612-1617.
22. Zuzarte V, Montero JA, Rodriguez-Leon J, Merino R, Rodrigues JC, Hurle JM. A new role for BMP5 during limb development acting through synergic activation of Smad and MAPK pathways. Dev Biol 2004; 272: 39-52.
23. Saleem M, Adhami VM, Ahmad N, Gupta S, Mukhtar H. Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model. Clin Cancer Res 2005; 11: 147-153.
24. Žbánková Š, Bryndová J, Kment M, Pácha J. Expression of 11β-hydroxysteroid dehydrogenase types 1 and 2 in colorectal cancer. Cancer Lett 2004; 210: 95-100.
25. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7 1267-1278.
26. Thiébault K, Mazelin L, Pays L, Llambi F, Joly M-O, Scoazec J-Y et al. The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment. Proc Natl Acad Sci USA 2003; 100: 4173-4178.
27. Gupta S, Hussain T, MacLennan GT, Fu P, Patel J, Mukhtar H. Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma. J Clin Oncol 2003; 21: 106-112.
28. Horvath LG, Henshall SM, Kench JG, Saunders DN, Lee C-S, Golovsky D et al. Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro. Clin Cancer Res 2004; 10 615-625.